National Cheng Kung University Hospital; Neurology

Tainan 704

0 studies enrolling now · 2 studies all time

What they study most

NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO)

Studies at this site

• Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) — Completed
• Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD) — Completed